Anavex Life Sciences Corp (AVXL)

[frrol]

Folks should note that the endpoints gauge for the Lecanemab trials were not odds ratio. They were (drum roll...) % mean change from baseline. Fun fact: It's the same for all AD trials. Another fun fact: Biogen disclosed the t-test # of tails. (And all p-vals were below .01)

Proper endpoint gauges and adequate disclosure really matter in biotech. Investors and analysts look for these. They don't look for cabals and fantasies.

We'll be getting a proper topline (and full) results disclosure for our AD trial at some point, which is pretty important. I hope some of the confused and paranoid are catching on as to why.